Continuing Medical Education

Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.
Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.
Upcoming Courses
Cancer Centers Survivorship Research Forum 2025
Sept. 18-19, 2025
Course format: In-person
Join us for the 3rd Biennial Cancer Centers Survivorship Research Forum, a two-day event where healthcare professionals can hear about the latest findings and gaps in cancer survivorship research, while connecting with colleagues and collaborators. Network with colleagues while engaging with leading experts through dynamic panel discussions, insightful presentations, and collaborative breakout sessions. Don't miss this opportunity to be at the forefront of survivorship research and innovation.
(Note that CME credit is not available for this forum.)
View forum agenda and register
Updates to Cancer Survivorship: Optimizing Care and Outcomes
Available until Jan. 28, 2028
Course format: Online; self-paced
This course is designed to educate clinicians on the latest advancements in cancer survivorship care, focusing on evidence-based strategies to enhance patient outcomes and address the unique needs of diverse cancer survivors.
View course and register
Grand Rounds
Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.
Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.